CMS IPO Change Creates Immediate Admission Denial Risk

(Inferred) Medicare Advantage plan argues that since the procedure was removed from the IPO list effective January 1, 2026, the inpatient admission lacks clinical necessity justification independent of IPO status, and that a short stay under two midnights should be reclassified to observation — citing Two-Midnight rule non-compliance and referencing Table 119 of the CY 2026 OPPS final rule.

Physician advisor should immediately audit all inpatient admissions for procedures in Table 119 (CY 2026 OPPS final rule, p. 888) to confirm contemporaneous Two-Midnight documentation exists in the admitting order, H&P, and progress notes. For pending denials, prepare a clinical rebuttal that reconstructs the Two-Midnight expectation from objective clinical indicators present at admission, not retrospective additions.

'Per CMS-1834-FC, removal from the IPO list does not mandate outpatient performance; the admitting physician exercised retained clinical judgment authority and documented a Two-Midnight expectation based on [specific comorbidities/complexity factors]. The Two-Midnight benchmark was met and the inpatient admission is consistent with CMS policy as codified in the CY 2026 OPPS final rule.'

(Inferred) MAC initiates a Targeted Probe and Educate audit identifying that the hospital's inpatient claim rate for procedures newly removed from the IPO list in CY 2026 has not declined proportionally — inferring that the hospital is continuing to admit patients inpatient based on historical IPO reliance rather than individualized Two-Midnight documentation, and issuing medical necessity denials across a statistically sampled claim set.

UR leadership should pull a pre-emptive internal audit of all Table 119 procedure admissions from January 1, 2026 forward, scoring each for Two-Midnight documentation completeness. Establish a CDI query workflow that fires an automatic prompt at order entry for any CPT in the IPO phase-out cohort, and present corrective action evidence to the MAC before the TPE progresses to full Additional Documentation Request phase.

'Each claim in this sample reflects individualized physician clinical judgment consistent with CMS-1834-FC; the Two-Midnight expectation was documented based on [specific per-case factors]. CMS policy explicitly preserves physician clinical judgment authority post-IPO removal, and the documentation in each record supports inpatient level of care under that standard.'

(Inferred) Medicare Advantage plan denies inpatient claim arguing that the procedure, formerly IPO-protected and therefore previously exempt from site-of-service PA scrutiny, now requires separate prior authorization for inpatient level of care under revised plan policy effective January 1, 2026 — and that the hospital failed to obtain updated PA before the admission, triggering a technical prior auth denial independent of clinical necessity.

Managed care team should immediately map all Table 119 procedures against each MA plan contract to identify which plans have updated their PA requirements post-January 1, 2026. For current denials on technical PA grounds, initiate a retrospective authorization appeal citing the plan's obligation to align PA criteria with clinical necessity standards and document that the clinical record supported inpatient admission. Update PA workflow to flag IPO-removed procedures at order entry before scheduling.

'The inpatient admission for this procedure was clinically appropriate under the Two-Midnight framework per CMS-1834-FC; CMS does not impose a separate PA requirement for IPO-removed procedures under Medicare FFS, and the plan's PA criteria must be consistent with CMS medical necessity standards. The clinical complexity documented in this record independently supports inpatient authorization.'